REGN

NASDAQStock

Regeneron Pharmaceuticals, Inc.

$750.03-24.29 (-3.13%)

52-Week Range

$483.07
$812.27

Key Stats

Market Cap

77.9B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.40

Volume

377.8K

Avg Volume

633.8K

Performance

1M

-1.10%

3M

+0.72%

6M

+30.39%

YTD

-3.83%

1Y

+8.28%

3Y

-2.63%

5Y

+54.28%

Price Chart

ETF Exposure

REGN is held by 381 ETFs

ETFFund NameWeight
BADB.A.D. ETF1.45%
XLVState Street Health Care Select Sector SPDR ETF1.40%
FLAGGlobal X - S&P 500 U.S. Market Leaders Top 50 ETF1.40%
IYHiShares U.S. Healthcare ETF1.38%
FCPIFIDELITY STOCKS FOR INFLATION ETF1.36%
LGCFThemes US Cash Flow Champions ETF1.34%
XBIState Street SPDR S&P Biotech ETF1.30%
NBFRInnovator Nasdaq-100 Managed 10 Buffer ETF1.24%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF1.23%
JAVAJPMorgan Active Value ETF1.23%
COWZPacer US Cash Cows 100 ETF1.22%
JEPIJPMorgan Equity Premium Income ETF1.20%
RNDFirst Trust Bloomberg R&D Leaders ETF1.19%
VHTVanguard Health Care ETF1.18%
DSTLDistillate U.S. Fundamental Stability & Value ETF1.12%
HEQQJPMorgan Nasdaq Hedged Equity Laddered Overlay ETF1.11%
WDNAWisdomTree BioRevolution Fund1.10%
IMCViShares Morningstar Mid-Cap Value ETF1.10%
JKIiShares Morningstar Mid-Cap Value ETF1.10%
PALCPacer Lunt Large Cap Multi-Factor Alternator ETF1.06%
RXLProShares - Ultra Health Care1.04%
FCFYFirst Trust S&P 500 Diversified Free Cash Flow ETF1.02%
QQQEDirexion NASDAQ-100 Equal Weighted Index ETF1.01%
IXJiShares Global Healthcare ETF0.99%
GERMETFMG Treatments, Testing and Advancements ETF0.99%
LSAFLeaderSharesTM AlphaFactor US Core Equity ETF0.98%
CANCTema Oncology ETF0.96%
ONEVState Street SPDR Russell 1000 Low Volatility Focus ETF0.95%
CLRGIQ Chaikin U.S. Large Cap ETF0.93%
CGGOCapital Group Global Growth Equity ETF0.84%
JOETVirtus Terranova U.S. Quality Momentum ETF0.83%
FLRGFIDELITY U.S. MULTIFACTOR ETF0.82%
TNXTT. Rowe Price Innovation Leaders ETF0.81%
WLDRAffinity World Leaders Equity ETF0.76%
VFMFVanguard U.S. Multifactor ETF0.76%
SYGSPDR MFS Systematic Growth Equity ETF0.75%
LSLTPacer Salt Low truBeta US Market ETF0.74%
SLTPacer Salt High truBeta US Market ETF0.74%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.74%
VETSPacer Military Times Best Employers ETF0.74%
VIRSPacer BioThreat Strategy ETF0.74%
PEXLPacer US Export Leaders ETF0.73%
JHMHJohn Hancock Multifactor Health Care ETF0.72%
LCDSJPMorgan Fundamental Data Science Large Core ETF0.71%
DGRWWisdomTree U.S. Quality Dividend Growth Fund0.71%
FWDAlliance Bernstein - AB Disruptors ETF0.68%
RAFEPIMCO RAFI ESG U.S. ETF0.63%
VFVAVanguard U.S. Value Factor ETF0.61%
AVIEAvantis Inflation Focused Equity ETF0.59%
RSPEInvesco ESG S&P 500 Equal Weight ETF0.58%
PreviousPage 2 of 8Next

About REGN ETF Exposure

Regeneron Pharmaceuticals, Inc. (REGN) is held by 381 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 77.9B, REGN is a widely held institutional stock. The stock currently trades at $750.03. Investors can gain exposure to REGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold REGN, sorted by portfolio weight.